skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Would appreciate your assessment of the merits of continuing to hold half-positions in BOX, NVDA, SQ, and SPOT, in search of above-average returns going forward and comfortable with risk. If you were on the sidelines, would you initiate new positions in any of the holdings, or alternatively are there merits in reducing any of these positions today in favour of more attractive risk/return opportunities in the US technology space (and if so, which tech opportunities have captured your recent favour)? Thanks for excellent services rendered.
Read Answer Asked by Michael on May 15, 2019
Q: I would like to buy a 5% position in one of these for a one year hold. I am looking for growth mainly, but also want to take risk into account. Which one would you suggest and why? Thank you for your help. Ian
Read Answer Asked by Ian on May 15, 2019
Q: I would appreciate your analysis of their latest results. The market seems to have yawned in reaction. Thanks as always.

Revenue Increase of 32.6% and Adjusted EBITDA Increase of 143%
--------------------------------------------------------------------
Revenue for the first quarter ended March 31, 2019 was $39.0 million, an increase of $9.6 million over the prior year period.

Gross profit grew to $14.3 million in the first quarter of 2019, compared to $10.6 million in the first quarter of 2018.

Adjusted EBITDA(2) was $3.5 million in the first quarter of 2019, compared to $1.4 million in the first quarter of 2018.

Investor Conference Call on May 14, 2019 at 8:00 a.m. ET
Read Answer Asked by karl on May 15, 2019
Q: My tfsa account has 110k.How much since inception has a person deposited including this year if max. deposit with no withdraws.
tnx u...
Read Answer Asked by tom on May 15, 2019
Q: This company continues to make the headlines with new contracts and good news... I know it is a Cannabis company which is overvalued based on current sales, revenue earnings etc, but they have a low P/S in relation to peers, positive EBITDA and positive cash flow from operations).

I own it already and recently asked a question after their 2nd quarter. Today they announce at $30 million agreement with Cronos Group for 18 months with an additional $30 million revenue potential PLUS a separate tolling agreement (which they also offer to multiple large Cannabis companies. They are close to EU GMP facility certification which will be a big step for them for sales to Europe and for medical cannabis sales. They have hinted at CPG deals in the works and with upcoming vape pens and edibles etc being legal in the fall it seems like there are lots of positive catalysts for this stock in particular. What to you would be a good way to value this type of company which focuses on extraction not dried flower sales. What are your thoughts on the recent deal announced?
Read Answer Asked by Michael on May 15, 2019
Q: Hello 5I team
What would be the smallest denomination you would deploy considering a $10(rounded up) trading fee. Would you buy at $100, $500, $1000, or greater, perhaps based on a percentage of total portfolio? I have accounts where dividends build up and this is the money I am looking at with this question. I do not want to turn them into DRIPs at this time.
Thank you
Jeremy
Read Answer Asked by Jeremy on May 15, 2019
Q: I have some cash to add to a small growth , non-registered portfolio, holding TSGI, SYz, COV . Looking at MCR or PHO . Would you recommend either of these or would you suggest an alternative. Or would you prefer just adding to one of the 3 existing ones.
Many thanks as always.
Read Answer Asked by Alexandra on May 15, 2019
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!